Once-weekly (70 mg/m2 ) vs twice-weekly (56 mg/m2 ) dosing of carfilzomib in patients with relapsed or refractory multiple myeloma: A post hoc analysis of the ENDEAVOR, A.R.R.O.W., and CHAMPION-1 trials
| Image |  |
|---|---|
| Description | scientific article published on 28 February 2020 |
| Author/s |
author: Anita Zahlten-Kumeli Zandra Klippel Khalid Mezzi Athanasios Dimopoulos Philippe Moreau María Victoria Mateos Thierry Facon Robert Z Orlowski Noopur Raje |
| Publication date | February 28, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |